The store will not work correctly when cookies are disabled.
N-[4-(tert-Butyl)thiazol-2-yl]-5-methyl-3-phenylisoxazole-4-carboxamide
ID: ALA4538433
PubChem CID: 17191007
Max Phase: Preclinical
Molecular Formula: C18H19N3O2S
Molecular Weight: 341.44
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: Cc1onc(-c2ccccc2)c1C(=O)Nc1nc(C(C)(C)C)cs1
Standard InChI: InChI=1S/C18H19N3O2S/c1-11-14(15(21-23-11)12-8-6-5-7-9-12)16(22)20-17-19-13(10-24-17)18(2,3)4/h5-10H,1-4H3,(H,19,20,22)
Standard InChI Key: AVBIJCXWANKDCU-UHFFFAOYSA-N
Molfile:
RDKit 2D
24 26 0 0 0 0 0 0 0 0999 V2000
16.1635 -11.3647 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.1574 -12.1860 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
16.9363 -12.4462 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.4275 -11.7868 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.9462 -11.1204 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.1577 -10.3269 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.5759 -9.7448 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.7916 -8.9539 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.5853 -8.7424 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.1613 -9.3203 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.9545 -10.1145 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.2446 -11.7929 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.6480 -12.5036 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
19.4693 -12.5097 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.9567 -11.8492 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
20.7355 -12.1087 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.7294 -12.9296 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.9468 -13.1774 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
21.4407 -13.3402 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.1520 -12.9296 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.4407 -14.1615 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.1520 -13.7509 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.6585 -11.0883 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
17.1809 -13.2259 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 2 0
4 5 1 0
5 1 2 0
6 5 1 0
7 6 2 0
8 7 1 0
9 8 2 0
10 9 1 0
11 10 2 0
6 11 1 0
4 12 1 0
12 13 1 0
13 14 1 0
15 14 1 0
15 16 1 0
16 17 2 0
17 18 1 0
18 14 2 0
17 19 1 0
19 20 1 0
19 21 1 0
19 22 1 0
12 23 2 0
3 24 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 341.44 | Molecular Weight (Monoisotopic): 341.1198 | AlogP: 4.66 | #Rotatable Bonds: 3 |
Polar Surface Area: 68.02 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 9.61 | CX Basic pKa: 0.02 | CX LogP: 4.94 | CX LogD: 4.93 |
Aromatic Rings: 3 | Heavy Atoms: 24 | QED Weighted: 0.75 | Np Likeness Score: -2.07 |
References
1. Jumppanen M, Kinnunen SM, Välimäki MJ, Talman V, Auno S, Bruun T, Boije Af Gennäs G, Xhaard H, Aumüller IB, Ruskoaho H, Yli-Kauhaluoma J.. (2019) Synthesis, Identification, and Structure-Activity Relationship Analysis of GATA4 and NKX2-5 Protein-Protein Interaction Modulators., 62 (17): [PMID:31431011] [10.1021/acs.jmedchem.9b01086] |